Early Data Show Ongoing Benefit of Bria-IMT in Small Breast Cancer Population

Bibliographic Details
Title: Early Data Show Ongoing Benefit of Bria-IMT in Small Breast Cancer Population
Authors: By:Nicholas Wrigley
Source: CancerNetwork (USA), March 20, 2023 News, 3pp
Abstract: Targeted immunotherapy agent Bria-IMT (SV-BR-1-GM) continued to yield clinical survival benefit in combination with retifanlimab (MGA012) in 11 patients with advanced, metastatic breast cancer who were enrolled in a phase 1/2 trial (NCT03328026) in 2021 or 2022, according to data published in a press release from BriaCell Therapeutics. Investigators reported a median progression-free survival (PFS) of 3.5 months, with 1 patient who continued to be progression free...
Database: NewsBank
FullText Text:
  Availability: 0
Header DbId: edsnbk
DbLabel: NewsBank
An: 190661711D3A4108
RelevancyScore: 625
AccessLevel: 6
PubType: News
PubTypeId: newspaperArticle
PreciseRelevancyScore: 625
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Early Data Show Ongoing Benefit of Bria-IMT in Small Breast Cancer Population
– Name: Author
  Label: Authors
  Group: Au
  Data: By:Nicholas Wrigley
– Name: TitleSource
  Label: Source
  Group: Src
  Data: CancerNetwork (USA), March 20, 2023 News, 3pp
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Targeted immunotherapy agent Bria-IMT (SV-BR-1-GM) continued to yield clinical survival benefit in combination with retifanlimab (MGA012) in 11 patients with advanced, metastatic breast cancer who were enrolled in a phase 1/2 trial (NCT03328026) in 2021 or 2022, according to data published in a press release from BriaCell Therapeutics. Investigators reported a median progression-free survival (PFS) of 3.5 months, with 1 patient who continued to be progression free...
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsnbk&AN=190661711D3A4108
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 3
    Titles:
      – TitleFull: Early Data Show Ongoing Benefit of Bria-IMT in Small Breast Cancer Population
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nicholas Wrigley
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 03
              Text: March 20, 2023
              Type: published
              Y: 2023
          Titles:
            – TitleFull: CancerNetwork (USA)
              Type: main
ResultId 1